MedPath

A Randomized placebo clinical study and life style interventionon Mesha Shringyadi Gugglu in Medovridhhi

Phase 1
Conditions
Health Condition 1: null- Patient with hypertryglyceridemia
Registration Number
CTRI/2016/03/006709
Lead Sponsor
IPGT and RA Gau Jamnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

S.cholesterol >200mg/dl or/and

S.Triglyceride >150mg/dl or/and

S.L.D.L >130mg/dl or /and

S.H.D.L <40mg/dl

Exclusion Criteria

Age below 25 and above 60 years

Patients suffering from type 1 dm and uncotrolled dm

patients having uncontrolled hypertention

past history of MI unstabe angina

renal disese liver disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to show changes in lipid proofile mainly S triglyceride levelTimepoint: to show changes in lipid proofile mainly S triglyceride level
Secondary Outcome Measures
NameTimeMethod
â?¢By providing better effect on hypertriglyceridemia,drug may also reduce the risk of insuline resistance diabetes, metabolic syndrome, pancreatitis & IHD.Timepoint: Cange in lipid profile
© Copyright 2025. All Rights Reserved by MedPath